首页|2.1亚型猪瘟病毒流行株E2蛋白单克隆抗体的制备及其抗原表位的鉴定

2.1亚型猪瘟病毒流行株E2蛋白单克隆抗体的制备及其抗原表位的鉴定

Preparation and antigenic epitope mapping of a specific monoclonal antibody against glycoprotein E2 of classical swine fever subgenotype 2.1 field strain

扫码查看
为获得仅与我国基因2.1亚型猪瘟病毒(CSFV)流行株反应的单克隆抗体(MAb),并揭示疫苗株与流行株E2蛋白抗原氨基酸的差异,本研究利用基因2.1亚型重组质粒pFastBac1-JL23 E2通过杆状病毒表达重组E2蛋白(rE2),并采用Ni柱纯化后经SDS-PAGE检测rE2的表达及纯化效果;采用western blot鉴定rE2的反应原性.SDS-PAGE及western blot结果表明经杆状病毒表达了基因2.1亚型CSFV E2蛋白,且其纯化效果和反应原性均较好.采用杂交瘤技术制备2.1基因亚型CSFV E2蛋白的单克隆抗体(MAb),采用亲和层析法纯化该MAb,采用BCA法测定其浓度及亚类.将79株1.1、2.1、2.2和2.3基因亚型的CSFV及1.1基因亚型的HCLV株和SM株感染PK-15细胞,72 h后采用IFA检测MAb与不同基因型CSFV的反应性;采用western blot鉴定MAb与10个基因亚型共18种CSFV代表株E2蛋白的反应性.采用IFA鉴定MAb与不同基因型CSFV的中和活性.结果显示,经IFA筛选后共获得16株分泌E2蛋白MAb的杂交瘤细胞株.其中仅一株MAb TCH061与所有2.1基因亚型(2.1a、2.1b、2.1c、2.1g、2.1h、2.1i、2.1j、2.1k、2.1l、2.1m、2.1n)CSFV感染的细胞反应后出现绿色荧光,与基因1.1亚型HCLV疫苗株和SM株以及其他基因型CSFV感染的细胞反应后均无绿色荧光;western blot结果显示,该MAb能够识别2.1基因亚型CSFV E2蛋白(2.1a、2.1b、2.1c、2.1g、2.1h、2.1i、2.1j),在90 ku处出现特异性条带,而与其他基因型CSFV E2蛋白均不反应.表明TCH061为2.1基因亚型CSFV E2蛋白特异性的MAb.MAb的纯化结果显示,在50 ku和25 ku处有明显条带,其浓度为1.70 μg/μL且该 MAb TCH061重链为IgG2a,轻链为κ链.中和活性结果显示,TCH061对JL23株(2.1b)、GDLF1株(2.1c)有一定的中和活性,但不能中和C株.分别以GD53株E2 4个不同区域的截短蛋白为抗原通过western blot初步确定MAb识别抗原表位的区域.利用CLC Sequence Viewer比对与MAb反应的CSFV E2蛋白氨基酸序列的差异,通过SWISS-MODEL预测MAb抗原表位的关键氨基酸位点.利用杆状病毒表达CSFV JL23株各位点突变后的E2蛋白,采用western blot鉴定各突变的E2蛋白与MAb TCH061的反应性.Western blot结果显示,TCH061的抗原表位位于E2蛋白的aa1~aa90,且其识别CSFV E2蛋白P20不识别L20的CSFV.通过SWISS-MODEL预测E2蛋白氨基酸序列的I18、G19、P20、L21、G22、A23和E24在空间上比较接近;MAb TCH061与JL23株I18M突变的E2蛋白反应,与G19K、P20L和L21P突变的E2蛋白均不反应,与G22K突变的E2蛋白反应性较弱,与HCLV E2蛋白不反应,但与HCLV L20P突变的E2蛋白反应.证实TCH061的抗原表位为19GPLG22,经PyMOL结构模拟确定其为空间构象表位;且除了aa20,其他位点在各基因型CSFV中均非常保守,表明P20是2.1基因亚型CSFV流行株E2蛋白抗原表位的关键氨基酸.综上所述,本研究首次获得一株区别于CSFV疫苗株和2.1基因亚型CSFV流行株的MAb TCH061,揭示了疫苗株与流行株E2蛋白氨基酸位点的差异,为研发猪瘟疫苗和CSFV流行株感染的血清学鉴别检测方法的建立提供了重要的MAb资源.
In order to develop the differential monoclonal antibody(MAbs)that specifically reacts with the dominant subgenotype 2.1 field strains of classical swine fever virus(CSFV)in China and to reveal the antigenic difference of E2 protein between the vaccine C-strain and the field strains,this study used subgenotype 2.1 recombinant plasmid pFastBac1-2.1 JL23 E2 by baculovirus expression recombinant E2 protein(rE2).The efficiency of expression and purification were assessed by SDS-PAGE following Ni column purification,and its reactivity was further evaluated using western blot analysis.The findings from both methods confirmed the expression of the subgenotype 2.1 CSFV E2 protein with commendable purification efficiency and reactivity.Monoclonal antibody(MAb)specific to the E2 protein of 2.1b subgenotype CSFV was prepared by hybridoma technique.79 strains of CSFV subgenotypes 1.1,2.1,2.2 and 2.3 were inoculated with PK-15 cells,and the reaction patterns of MAb to different genotypes of CSFV tested by IFA after 72 hours.The reactivity between MAb and 18 E2 proteins derived from CSFV belonging to 10 subgenotypes were verified by western blot.The MAb was subsequently purified through affinity chromatlography,and its concentration was precisely determined using BCA method and detection subclasses of MAb.The immunofluorescence assay(IFA)was used to identify the neutralizing activity of MAb against the diverse genotypes of CSFV.Following IFA identification,the positive nderwent additional subcloning,leading to the acquisition of 16 hybridoma cells that secreted the E2 MAb,The IFA results singled out one particular MAb,TCH061,which exhibited a unique reactivity profile,binding exclusively to cells infected with all variants of subgenotype CSFV 2.1(2.1a,2.1b,2.1c,2.1g,2.1h,2.1i,2.1j,2.1k,2.1l,2.1m,2.1n),while showing no reaction to the vaccine strain or other subgenotype CSFV.Western blot results showed that the TCH061 could specifically recognize the E2 protein subgenotype of CSFV 2.1(2.1a,2.1b,2.1c,2.1g,2.1h,2.1i,2.1j),with a specific band at 90ku,while it remained unreactive to E2 proteins from other genotype CSFV.The results indicated that TCH061 was a specific MAb of CSFV E2 protein of gene subgenotype 2.1.The purification of TCH061 yielded distinct bands at 50ku and 25ku,with the MAb concentration quantified at 1.70μg/μL.The MAb TCH061 heavy chain was IgG2a,and the light chain was kappa chain.The IFA results of MAb neutralizing activity showed that TCH061 had certain neutralizing activity against JL23 strain(2.1b)and GDLF1 strain(2.1c),but could not neutralize C strain.Further exploration into the antigenic epitopes of the E2 protein was conducted using truncated proteins from four different regions of the GD53 strain as antigens,with the reactivity being preliminarily mapped by western blot.Utilizing CLC Sequence Viewer and SWISS-MODEL,we compared the amino acid sequences of the CSFV E2 protein reactive to the MAb,predicting key amino acid sites for antigen recognition.Through a series of point mutations in the E2 protein of the CSFV JL23 strain expressed by baculovirus,the reactivity of the mutated E2 protein with MAb TCH061 was identified by western blot.The results showed the epitope recognized by TCH061 within the first 90 amino acids of the E2 protein.Amino acid sequence alignment within this region showed that TCH061 recognized P20,but not recognized L20 in E2 protein of CSFV,and I18,G19,P20,L21,G22,A23 and E24 were spatially similar predicted,and MAb TCH061 reacted with the I18M mutant E2 protein of JL23 strain,and did not react with the E2 protein mutated in G19K,P20L and L21P,and was weakly reactive with the E2 protein with the G22K mutation,but did not react with the E2 protein with the HCLV L20P mutation.It was confirmed that the amino acid sequence of TCH061 to recognize the epitope of E2 protein was 19GPLG22,which was determined as a spatial conformational epitope by PyMOL structural simulation.Except for aa20,other sites were very conserved in each genotype CSFV,indicating that P20 was a key amino acid for MAb TCH061 to recognize the epitope of E2 protein of subtype 2.1 CSFV field strains.In summary,this study obtained a MAb TCH061 for the first time to distinguish between CSFV vaccine strain and CSFV subtype 2.1 field strain,revealing the difference in antigenic amino acid sites of E2 protein between vaccine strain and field strain,and providing an important MAb resource for the development of serologic identification detection methods for swine fever vaccine and CSFV field strain infection.

CSFVmonoclonal antibody(MAb)viral reactivityantigenic epitope

张艺潇、吴梦、米士江、刘钟迪、涂长春、龚文杰

展开 >

吉林大学 动物医学学院,吉林 长春 130062

中国农业科学院 长春兽医研究所,吉林 长春 130012

重庆市畜牧科学院,重庆 408599

猪瘟病毒 单克隆抗体 病毒反应性 抗原表位

国家自然科学基金面上项目

32072843

2024

中国预防兽医学报
中国农业科学院哈尔滨兽医研究所

中国预防兽医学报

CSTPCD北大核心
影响因子:0.674
ISSN:1008-0589
年,卷(期):2024.46(5)